Acinetobacter baumannii has recently been known as a major cause of hospital-and
community-acquired infections. Carbapenem resistant A. baumanni (CRAB) has been …

Acinetobacter baumannii has recently been known as a major cause of hospital-and
community-acquired infections. Carbapenem resistant A. baumanni (CRAB) has been …

The increasing number of carbapenem-resistant Acinetobacter baumannii clinical isolates is
a major concern, which restricts therapeutic options for treatment of serious infections …

Background and objective Acinetobacter baumannii (A. baumannii) is a common
nosocomial pathogen, which developed multi-drug-resistance to different classes of …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …

Acinetobacter baumannii has emerged as a problematic multidrug-resistant (MDR)
pathogen worldwide. The aim of this study was to characterize clinical isolates of A …

This study characterized the occurrence of carbapenem resistance of Acinetobacter
baumannii isolates in a tertiary care hospital in Saudi Arabia. From January 2010 until …

It has previously been shown that carbapenem-resistant Acinetobacter baumannii are
frequently detected in Saudi Arabia. The present study aimed to identify the epidemiology …

Background In the last decade, incidences of carbapenem‐resistant Acinetobacter
baumannii have been increasingly reported worldwide. Consequently, A. baumannii was …

Acinetobacter baumannii (A. baumannii) represents a global threat owing to its ability to
resist most of the currently available antimicrobial agents. Moreover, emergence of …